Immature rice grains may contain ‘a remarkable amount of bioactive compounds’, giving them great potential for applications in nutraceutical foods, according to new research.
Lonza has confirmed that its planned vitamin B3 production expansion will occur in China, where the firm expects a double digit surge in demand for the ingredient in coming years.
A new partnership with chemical group Solvay will enable the distribution of a low dosage prebiotic food ingredient with multiple food and drink applications within Europe, the Middle East and Africa, claims Tate & Lyle.